Challenging Case Review: Breast Cancer
As a result of the therapeutic advances and clinical research affecting the management of patients with breast cancer, clinicians can benefit by comparing their individual skills of diagnosis, treatment, and management of patients with their peers. This peer interaction is an integral part in enhancing clinical decision-making skills that can improve patient care.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
The Future of Telemedicine in Oncology
Education in this area is important because the broad use of telemedicine in oncology was quickly implemented in response to the COVID-19 pandemic. As best practices are being considered, the future of telemedicine in oncology and how reimbursement and legislation will support it, is worthy of discussion.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Management of Patients with Aggressive Non-Melanoma Skin Cancers
Even though the prognosis for patients with non-melanoma skin cancer is generally good, there are subsets of patients who are prone to recurrence or regional and distant metastasis. Awareness of aggressive disease features is, thus, crucial to identify such patients. It is also important for clinicians to stay up-to-date on the current treatment options for these patients.
Category
  • Skin Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Updates to the Management of Patients with Relapsed/Refractory Indolent B-Cell Lymphomas
Oncologists and hematologists need to maintain high awareness of the recently approved targeted therapies and the precise indications for their use so that these can be incorporated in routine clinical practice in the appropriate patient population.
Category
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Plenary Session – The Patient Journey: Equity of Cancer Care
Experts will discuss promising and best practices to provide equitable cancer care to sexual, gender, and racial minority patients. The session will also feature an update on the Elevating Cancer Equity initiative as well as policy initiatives focused on improving health equity. Additionally, leading cancer centers will share successful programs they have implemented to engage underserved communities.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Management of Patients with Advanced Melanoma
Despite recent advancements in immunotherapies and targeted therapies for melanoma patients with late stage disease, treatment options for these patients are not limited to systemic therapies. An overview of current challenges facing this patient population, as well as an in-depth analysis of treatment modalities, will be beneficial to the oncology care team.
Category
  • Melanoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Non-Small Cell Lung Cancer: Management of Patients with Resectable Disease
Many patients with stages I to IIIA NSCLC are eligible for surgery followed by adjuvant therapy. Multidisciplinary evaluation is recommended to decide whether patients with stages I to IIIA NSCLC have resectable disease and to determine the most appropriate surgical procedure. The NCCN Guidelines now recommend biomarker testing for EGFR mutations in patients with completely resected stages IB to IIIA NSCLC to determine whether they are eligible for certain adjuvant targeted therapy. Previously, the NCCN Guidelines only recommended biomarker testing for eligible patients with advanced NSCLC.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Targeted Therapy for Patients with Metastatic Non-Small Cell Lung Cancer
The rapid pace of updates to the NCCN Guidelines for NSCLC makes it challenging for health care providers to stay informed about current recommendations, including how to assess for and manage side effects with the newer agents.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Updates to Management of Patients with Multiple Myeloma
To navigate through the complex treatment landscape, physicians and other oncology care providers must understand the evolving therapeutic options and guidelines for administration of the available therapies in the context of the patient's therapeutic and disease history. The increasing complexity of myeloma treatment warrants rigorous efforts to provide adequate supportive care and preserve the quality of life of patients.
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Challenging Case Review: Non-Small Cell Lung Cancer
As a result of the therapeutic advances and clinical research affecting the management of patients with non-small cell lung cancer, clinicians can benefit by comparing their individual skills of diagnosis, treatment, and management of patients with their peers. This peer interaction is an integral part in enhancing clinical decision-making skills that can improve patient care.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages